This executive order recites the need to advance women’s health. It directs the secretary of health and human services to establish a women’s health division within the National Institutes of Health. The division is to (a) increase the scientific review of women’s health conditions in all phases of life that remain understudied or insufficiently understood; (b) promote innovation and advanced research technologies to accelerate time to diagnosis and improve access to high-quality prevention, treatment, specialized healthcare services, personalized medicine and coordinated care delivery for women’s health conditions; (c) support data collection and research methodologies that improve understanding sex-specific health outcomes and increase inclusion of women and girls in clinical trials; and (d) facilitate translation of scientific discoveries into clinical practice and public health implementation in federal, state and local jurisdictions.
The order establishes the White House women’s health task force, and the department of Health and Human Services shall provide funding for the administrative cost of the task force. The task force is to ensure that the federal government pursues a comprehensive approach to women’s health that recognizes evolving health needs from infancy through aging. The task force is to focus on (1) advancing the science of women’s health through strengthening research and initiatives to improve prevention, early detection, diagnosis, treatment and long-term health outcomes for women and girls; (2) increasing innovation and implementation of women’s health research; (3) supporting education and research into coordinated, preventative and woman-centered care; and (4) consulting with states, tribal nations, local jurisdictions, the private sector, philanthropic entities and other relevant stakeholders on the best strategies to translate research into practice.
Finally, the order revokes Executive Order 14120 of March 18, 2024 (Advancing Women’s Health Research and Innovation) and Presidential Memorandum of November 13, 2023 (White House Initiative on Women’s Health Research).